These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 34385077)

  • 1. Redox-dependent cytotoxicity of ferrocene derivatives and ROS-activated prodrugs based on ferrocenyliminoboronates.
    Věžník J; Konhefr M; Fohlerová Z; Lacina K
    J Inorg Biochem; 2021 Nov; 224():111561. PubMed ID: 34385077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tuning the structure of aminoferrocene-based anticancer prodrugs to prevent their aggregation in aqueous solution.
    Daum S; Babiy S; Konovalova H; Hofer W; Shtemenko A; Shtemenko N; Janko C; Alexiou C; Mokhir A
    J Inorg Biochem; 2018 Jan; 178():9-17. PubMed ID: 29028541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Boronic Acid Derivatives as an Active Form of N-Alkylaminoferrocene-Based Anticancer Prodrugs and Their Radiolabeling with
    Daum S; Toms J; Reshetnikov V; Özkan HG; Hampel F; Maschauer S; Hakimioun A; Beierlein F; Sellner L; Schmitt M; Prante O; Mokhir A
    Bioconjug Chem; 2019 Apr; 30(4):1077-1086. PubMed ID: 30768258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of aminoferrocene-based prodrugs against prostate cancer.
    Schikora M; Reznikov A; Chaykovskaya L; Sachinska O; Polyakova L; Mokhir A
    Bioorg Med Chem Lett; 2015 Sep; 25(17):3447-50. PubMed ID: 26206503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoferrocene-based prodrugs activated by reactive oxygen species.
    Hagen H; Marzenell P; Jentzsch E; Wenz F; Veldwijk MR; Mokhir A
    J Med Chem; 2012 Jan; 55(2):924-34. PubMed ID: 22185340
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ROS-Responsive N-Alkylaminoferrocenes for Cancer-Cell-Specific Targeting of Mitochondria.
    Reshetnikov V; Daum S; Janko C; Karawacka W; Tietze R; Alexiou C; Paryzhak S; Dumych T; Bilyy R; Tripal P; Schmid B; Palmisano R; Mokhir A
    Angew Chem Int Ed Engl; 2018 Sep; 57(37):11943-11946. PubMed ID: 30035345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ROS-activated anticancer prodrugs: a new strategy for tumor-specific damage.
    Peng X; Gandhi V
    Ther Deliv; 2012 Jul; 3(7):823-33. PubMed ID: 22900465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aminoferrocene-based prodrugs and their effects on human normal and cancer cells as well as bacterial cells.
    Marzenell P; Hagen H; Sellner L; Zenz T; Grinyte R; Pavlov V; Daum S; Mokhir A
    J Med Chem; 2013 Sep; 56(17):6935-44. PubMed ID: 23931109
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Reshetnikov V; Özkan HG; Daum S; Janko C; Alexiou C; Sauer C; Heinrich MR; Mokhir A
    Molecules; 2020 May; 25(11):. PubMed ID: 32486084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Ferrocene Compounds as Selective Cyclooxygenase (COX-2) Inhibitors: Design, Synthesis, Cytotoxicity and Enzyme-inhibitory Activity.
    Farzaneh S; Zeinalzadeh E; Daraei B; Shahhosseini S; Zarghi A
    Anticancer Agents Med Chem; 2018; 18(2):295-301. PubMed ID: 28971779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of a Newly Synthesized Ferrocene Derivative against MCF-7 Breast Cancer Cells and Spheroid Stem Cells through ROS Production and Inhibition of JAK2/STAT3 Signaling Pathway.
    Nourbakhsh M; Farzaneh S; Taghikhani A; Zarghi A; Noori S
    Anticancer Agents Med Chem; 2020; 20(7):875-886. PubMed ID: 31893999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reactive oxygen species (ROS)-responsive ferrocene-polymer-based nanoparticles for controlled release of drugs.
    Na Y; Lee JS; Woo J; Ahn S; Lee E; Il Choi W; Sung D
    J Mater Chem B; 2020 Mar; 8(9):1906-1913. PubMed ID: 32043093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Voltammetric response of ferroceneboronic acid to diol and phenolic compounds as possible pollutants.
    Takahashi S; Abiko N; Haraguchi N; Fujita H; Seki E; Ono T; Yoshida K; Anzai J
    J Environ Sci (China); 2011; 23(6):1027-32. PubMed ID: 22066227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Redox-Channeling Polydopamine-Ferrocene (PDA-Fc) Coating To Confer Context-Dependent and Photothermal Antimicrobial Activities.
    Song J; Liu H; Lei M; Tan H; Chen Z; Antoshin A; Payne GF; Qu X; Liu C
    ACS Appl Mater Interfaces; 2020 Feb; 12(7):8915-8928. PubMed ID: 31971763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A small-molecule Fenton reagent for self-augmented chemodynamic therapy by intelligently regulating intracellular acidosis.
    Wang K; Liu X; Jia Y; Pan L; Shi M; Pan W; Li N; Tang B
    Chem Commun (Camb); 2024 Apr; 60(36):4773-4776. PubMed ID: 38602162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis, electrochemistry, DNA binding and in vitro cytotoxic activity of tripodal ferrocenyl bis-naphthalimide derivatives.
    Fan YR; Wang BJ; Jia DG; Yang XB; Huang Y
    J Inorg Biochem; 2021 Jun; 219():111425. PubMed ID: 33831713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ferrocene-Containing Impiridone (ONC201) Hybrids: Synthesis, DFT Modelling, In Vitro Evaluation, and Structure⁻Activity Relationships.
    Bárány P; Oláh RS; Kovács I; Czuczi T; Szabó CL; Takács A; Lajkó E; Láng O; Kőhidai L; Schlosser G; Bősze S; Mező G; Hudecz F; Csámpai A
    Molecules; 2018 Sep; 23(9):. PubMed ID: 30177664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical Tools for Targeted Amplification of Reactive Oxygen Species in Neutrophils.
    Reshetnikov V; Hahn J; Maueröder C; Czegley C; Munoz LE; Herrmann M; Hoffmann MH; Mokhir A
    Front Immunol; 2018; 9():1827. PubMed ID: 30150984
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox behavior and biological properties of ferrocene bearing porphyrins.
    Lippert R; Shubina TE; Vojnovic S; Pavic A; Veselinovic J; Nikodinovic-Runic J; Stankovic N; Ivanović-Burmazović I
    J Inorg Biochem; 2017 Jun; 171():76-89. PubMed ID: 28371681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ferrocenes as potential chemotherapeutic drugs: synthesis, cytotoxic activity, reactive oxygen species production and micronucleus assay.
    Pérez WI; Soto Y; Ortíz C; Matta J; Meléndez E
    Bioorg Med Chem; 2015 Feb; 23(3):471-9. PubMed ID: 25555734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.